UNLIMITED TURBO LONG - BAXTER INTERNATIONAL Share Price

Certificat

DE000PE880K2

Market Closed - Deutsche Boerse AG 20:50:33 16/05/2024 BST
1.33 EUR -1.48% Intraday chart for UNLIMITED TURBO LONG - BAXTER INTERNATIONAL
Current month-27.42%
1 month-25.82%
Date Price Change
16/05/24 1.33 -1.48%
15/05/24 1.35 +1.50%
14/05/24 1.33 -2.92%
13/05/24 1.37 -1.44%
10/05/24 1.39 -0.71%

Delayed Quote Deutsche Boerse AG

Last update May 16, 2024 at 08:50 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying BAXTER INTERNATIONAL INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PE880K
ISINDE000PE880K2
Date issued 16/02/2023
Strike 21.37 $
Maturity Unlimited
Parity 10 : 1
Emission price 1.95
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.7
Lowest since issue 1.05

Company Profile

Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - medicines and medical devices (33.8%): products intended for treating hemophilia (substitution clotting factors) and immune deficiencies (multi-purpose immunoglobins), and used in intensive care (human albumin) and biosurgery (fibrin adhesive, surgical gel, bone substitutes, hemostatic compresses, etc.); - kidney dialysis drugs and equipment (30.1%); - systems for delivering medications and intravenous therapy (15.2%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, etc.; - other (20.1%). Export accounts for 52.7% of net sales.
Sector
-
More about the company

Ratings for Baxter International Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Baxter International Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
35.43 USD
Average target price
46.47 USD
Spread / Average Target
+31.15%
Consensus